Huateng Pharma, a professional pharmaceutical intermediate supplier, provides baloxavir marboxil intermediate 7,8-Difluorodibenzo[b,e]thiepin-11(6H)-one (CAS No. 2136287-66-4) with high quality and purity, which is the treatment of influenza in individuals who are at increased risk of developing flu-related complications.
*The following content is generated by AI and is for reference only.
7,8-Difluorodibenzo[b,e]thiepin-11(6H)-one is a specialized fluorinated heterocyclic compound belonging to the dibenzothiepine class. With the molecular formula C14H8F2OS and a molecular weight of approximately 262.28 g/mol, this chemical features a tricyclic core structure where two benzene rings are fused to a central seven-membered thiopyran ring containing a ketone group at the 11-position. The presence of two fluorine atoms at the 7 and 8 positions significantly alters its electronic properties compared to non-fluorinated analogs, enhancing metabolic stability and lipophilicity, which are critical attributes for pharmaceutical applications. While specific commercial CAS registry numbers may vary depending on the supplier or slight variations in nomenclature conventions, this compound is primarily utilized as a valuable synthetic intermediate in medicinal chemistry research. Its structural framework serves as a scaffold for developing novel therapeutics targeting central nervous system disorders, including potential treatments for anxiety, depression, and schizophrenia, given the known pharmacological activity of dibenzothiepine derivatives. Researchers often employ this molecule in the construction of more complex drug candidates by functionalizing the ketone moiety or performing further substitutions on the aromatic rings. Furthermore, the fluorine substituents can improve binding affinity to specific biological receptors by modulating the electron density distribution within the molecule. Due to its high reactivity and specific steric profile, it is frequently used in academic laboratories to explore structure-activity relationships (SAR) during early-stage drug discovery. Although not typically found in consumer goods, its role in advancing modern pharmacology is substantial. Safety handling requires standard laboratory precautions, as with many halogenated organic compounds, ensuring proper ventilation and personal protective equipment to avoid exposure to dust or vapors. As the demand for targeted therapies grows, derivatives like 7,8-difluorodibenzo[b,e]thiepin-11(6H)-one remain essential tools for chemists designing next-generation medicines with optimized efficacy and safety profiles.